Leonardo Drs, Inc. Earnings

Leonardo Drs, Inc.’s revenue jumped 16.13% since last year same period to $799Mn in the Q1 2025. On a quarterly growth basis, Leonardo Drs, Inc. has generated -18.55% fall in its revenue since last 3-months.

Leonardo Drs, Inc.’s net profit jumped 72.41% since last year same period to $50Mn in the Q1 2025. On a quarterly growth basis, Leonardo Drs, Inc. has generated -43.82% fall in its net profits since last 3-months.

Leonardo Drs, Inc.’s net profit margin jumped 48.46% since last year same period to 6.26% in the Q1 2025. On a quarterly growth basis, Leonardo Drs, Inc. has generated -31.02% fall in its net profit margins since last 3-months.

Leonardo Drs, Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 47.73.

Leonardo Drs, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.17 - a -53.24% fall from last quarter’s estimates.

Leonardo Drs, Inc.’s earning per share (EPS) estimates for the current year stand at 0.17.

Leonardo Drs, Inc.’s earning per share (EPS) jumped 42.86% since last year same period to 0.2 in the Q1 2025. This indicates that the Leonardo Drs, Inc. has generated 42.86% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Leonardo Drs, Inc.’s return on assets (ROA) stands at 0.05.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Leonardo Drs, Inc.’s return on equity (ROE) stands at 0.1.

Leonardo Drs, Inc. declared 0.09 dividend per share during the earnings announcement for Q1 2025.